Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00643721 · ClinicalTrials.gov registry record

Body Water Content Sensor

A clinical trial, sponsored by State University of New York - Upstate Medical University.

Terminated
Registry status
12
Enrollment target

NCT00643721: Clinical Trial study, sponsored by State University of New York - Upstate Medical University.

NCT00643721 is a clinical trial that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00643721 was terminated before completion, sponsored by State University of New York - Upstate Medical University.

TERMINATED
Registry status
12 participants
Enrollment target

Study Summary

Evaluation of hydration status during exercise and heat exposure.

Interventions

  • OTHER dehydration

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2007-09
Est. Completion 2008-04

Why NCT00643721 stopped before completion

NCT00643721 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which dehydration is the first listed.

NCT00643721 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00643721 about?

NCT00643721 is a clinical study titled "Body Water Content Sensor". Evaluation of hydration status during exercise and heat exposure.

What is the current status of trial NCT00643721?

This trial is currently terminated. The enrollment target is 12 participants. The study started on 2007-09. Estimated completion is 2008-04.

What interventions are being tested in trial NCT00643721?

The interventions under investigation include: dehydration (OTHER).

Who is sponsoring clinical trial NCT00643721?

This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00643721, the US trial registry maintained by the National Library of Medicine. NCT00643721 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.